Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeri Kim

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Cancer Medicine|December 21, 2025
Integrating NLP to Enhance Algorithmic Identification of Metastatic and Castration-Resistant Prostate Cancer in Large Claims-Based StudiesShannon R Stock, Joshua A Parrish, Michael T Burns, et al.
Cancer Research|July 19, 2005
Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived productsJeri Kim, Peiying Yang, Milind Suraokar, et al.
The Prostate|September 21, 2007
Employing the treatment-free interval of intermittent androgen ablation to screen candidate prostate cancer therapiesShifeng Mao, Danai D Daliani, Xuemei Wang, et al.
BJU International|February 26, 2015
Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillancePatricia A Parker, John W Davis, David M Latini, et al.
BJU International|January 29, 2013
Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillanceJeri Kim, James Ebertowski, Matthew Janiga, et al.
Neoplasia (New York, N.Y.)|April 1, 2005
Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epitheliaVemparala Subbarayan, Xiao-Chun Xu, Jeri Kim, et al.
Nature Biotechnology|December 24, 2002
Fingerprinting the circulating repertoire of antibodies from cancer patientsPaul J Mintz, Jeri Kim, Kim-Anh Do, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2015
Discovery and horizontal follow-up of an autoantibody signature in human prostate cancerPaul J Mintz, Anna Cecilia Rietz, Marina Cardó-Vila, et al.
Molecular Cancer Research : MCR|July 20, 2007
Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cellsChien-Jui Cheng, Xiang-cang Ye, Funda Vakar-Lopez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancerSue-Hwa Lin, Yu-Chen Lee, Michel B Choueiri, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Cancer Medicine|December 21, 2025
Integrating NLP to Enhance Algorithmic Identification of Metastatic and Castration-Resistant Prostate Cancer in Large Claims-Based StudiesShannon R Stock, Joshua A Parrish, Michael T Burns, et al.
Cancer Research|July 19, 2005
Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived productsJeri Kim, Peiying Yang, Milind Suraokar, et al.
The Prostate|September 21, 2007
Employing the treatment-free interval of intermittent androgen ablation to screen candidate prostate cancer therapiesShifeng Mao, Danai D Daliani, Xuemei Wang, et al.
BJU International|February 26, 2015
Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillancePatricia A Parker, John W Davis, David M Latini, et al.
BJU International|January 29, 2013
Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillanceJeri Kim, James Ebertowski, Matthew Janiga, et al.
Neoplasia (New York, N.Y.)|April 1, 2005
Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epitheliaVemparala Subbarayan, Xiao-Chun Xu, Jeri Kim, et al.
Nature Biotechnology|December 24, 2002
Fingerprinting the circulating repertoire of antibodies from cancer patientsPaul J Mintz, Jeri Kim, Kim-Anh Do, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2015
Discovery and horizontal follow-up of an autoantibody signature in human prostate cancerPaul J Mintz, Anna Cecilia Rietz, Marina Cardó-Vila, et al.
Molecular Cancer Research : MCR|July 20, 2007
Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cellsChien-Jui Cheng, Xiang-cang Ye, Funda Vakar-Lopez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancerSue-Hwa Lin, Yu-Chen Lee, Michel B Choueiri, et al.
Pageof 11